Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316962264> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2316962264 abstract "Triple negative breast cancer (TNBC) accounts for approximately 15-20% of total invasive breast cancers. This subtype of cancer is often correlated with poor prognosis, visceral metastases and relapse. Molecular characterization reveals that these tumors are negative for hormone receptors and they often develop chemo resistance. Tumor microenvironment, among other factors, has emerged as a definite player in the progression of breast cancer and may also confer chemo resistance. In the current study, we demonstrate that MDA-MB-231 cells show greater resistance to paclitaxel in heterotypic culture with RMF/EG-hTERT (reduction mammary fibroblast with enhanced GFP) as compared to homotypic culture. Further, we show that RMF/EG-hTERT cells can enhance the motility of MDA-MB-231 cells in trans well migration assays, which could be attenuated by the TGF-β inhibitor sRIII (soluble receptor type III). TGF-β signaling was shown to activate pro-survival pathways like PI3K/Akt and MAPK/ERK pathways in mammary fibroblasts suggesting that they may mediate the paracrine tumor-promoting activity of TGF-β. Autocrine TGF-β signaling has been shown to promote EMT and cancer stem cell-like features in TNBC cells and appears to be a potential therapeutic target. We show that paclitaxel in combination with sRIII was more effective in inhibiting the growth of MDA-MB-231 cells than either agent alone. The combination of a TGF-β inhibitor with paclitaxel was also more effective in inhibiting tumor sphere formation than either agent alone. Our future research will be focused on the mechanisms of autocrine and paracrine TGF-β signaling in mediating chemo resistance and the tumor-promoting activity of mammary stromal cells. Our research will reveal the potential use of TGF-β inhibitors as novel therapeutics in combination with chemotherapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 542. doi:10.1158/1538-7445.AM2011-542" @default.
- W2316962264 created "2016-06-24" @default.
- W2316962264 creator A5009639926 @default.
- W2316962264 creator A5037380859 @default.
- W2316962264 date "2011-04-15" @default.
- W2316962264 modified "2023-09-27" @default.
- W2316962264 title "Abstract 542: TGF-β inhibitors enhance chemotherapeutic efficacy via abrogation of autocrine and paracrine signaling in a triple negative breast cancer model" @default.
- W2316962264 doi "https://doi.org/10.1158/1538-7445.am2011-542" @default.
- W2316962264 hasPublicationYear "2011" @default.
- W2316962264 type Work @default.
- W2316962264 sameAs 2316962264 @default.
- W2316962264 citedByCount "0" @default.
- W2316962264 crossrefType "proceedings-article" @default.
- W2316962264 hasAuthorship W2316962264A5009639926 @default.
- W2316962264 hasAuthorship W2316962264A5037380859 @default.
- W2316962264 hasConcept C121608353 @default.
- W2316962264 hasConcept C126322002 @default.
- W2316962264 hasConcept C128240485 @default.
- W2316962264 hasConcept C170493617 @default.
- W2316962264 hasConcept C2776107976 @default.
- W2316962264 hasConcept C2777292972 @default.
- W2316962264 hasConcept C2780110267 @default.
- W2316962264 hasConcept C502942594 @default.
- W2316962264 hasConcept C530470458 @default.
- W2316962264 hasConcept C64863464 @default.
- W2316962264 hasConcept C71924100 @default.
- W2316962264 hasConcept C7876069 @default.
- W2316962264 hasConcept C86803240 @default.
- W2316962264 hasConcept C96232424 @default.
- W2316962264 hasConceptScore W2316962264C121608353 @default.
- W2316962264 hasConceptScore W2316962264C126322002 @default.
- W2316962264 hasConceptScore W2316962264C128240485 @default.
- W2316962264 hasConceptScore W2316962264C170493617 @default.
- W2316962264 hasConceptScore W2316962264C2776107976 @default.
- W2316962264 hasConceptScore W2316962264C2777292972 @default.
- W2316962264 hasConceptScore W2316962264C2780110267 @default.
- W2316962264 hasConceptScore W2316962264C502942594 @default.
- W2316962264 hasConceptScore W2316962264C530470458 @default.
- W2316962264 hasConceptScore W2316962264C64863464 @default.
- W2316962264 hasConceptScore W2316962264C71924100 @default.
- W2316962264 hasConceptScore W2316962264C7876069 @default.
- W2316962264 hasConceptScore W2316962264C86803240 @default.
- W2316962264 hasConceptScore W2316962264C96232424 @default.
- W2316962264 hasLocation W23169622641 @default.
- W2316962264 hasOpenAccess W2316962264 @default.
- W2316962264 hasPrimaryLocation W23169622641 @default.
- W2316962264 hasRelatedWork W1527873462 @default.
- W2316962264 hasRelatedWork W1965246756 @default.
- W2316962264 hasRelatedWork W1982624034 @default.
- W2316962264 hasRelatedWork W1990842005 @default.
- W2316962264 hasRelatedWork W2001472847 @default.
- W2316962264 hasRelatedWork W2052332480 @default.
- W2316962264 hasRelatedWork W2067411772 @default.
- W2316962264 hasRelatedWork W2114639059 @default.
- W2316962264 hasRelatedWork W2481292978 @default.
- W2316962264 hasRelatedWork W2606292547 @default.
- W2316962264 hasRelatedWork W2735306866 @default.
- W2316962264 hasRelatedWork W2739612303 @default.
- W2316962264 hasRelatedWork W2793624536 @default.
- W2316962264 hasRelatedWork W2794710392 @default.
- W2316962264 hasRelatedWork W2803985368 @default.
- W2316962264 hasRelatedWork W2885654557 @default.
- W2316962264 hasRelatedWork W2992201391 @default.
- W2316962264 hasRelatedWork W3035033806 @default.
- W2316962264 hasRelatedWork W3040550542 @default.
- W2316962264 hasRelatedWork W3107639073 @default.
- W2316962264 isParatext "false" @default.
- W2316962264 isRetracted "false" @default.
- W2316962264 magId "2316962264" @default.
- W2316962264 workType "article" @default.